Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Down – Should You Sell?

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $19.08, but opened at $18.25. Daiichi Sankyo shares last traded at $18.66, with a volume of 28,219 shares trading hands.

Daiichi Sankyo Stock Performance

The firm’s 50-day simple moving average is $19.05 and its two-hundred day simple moving average is $21.96. The company has a current ratio of 2.69, a quick ratio of 1.85 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $35.48 billion, a PE ratio of 17.18, a PEG ratio of 1.15 and a beta of -0.35.

Daiichi Sankyo (OTCMKTS:DSNKY) last issued its quarterly earnings results on Thursday, January 29th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.05. The business had revenue of $3.65 billion for the quarter, compared to the consensus estimate of $3.88 billion. Daiichi Sankyo had a return on equity of 18.64% and a net margin of 14.83%. On average, equities research analysts expect that Daiichi Sankyo Co., Ltd. – Sponsored ADR will post 0.73 earnings per share for the current fiscal year.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.